Regulus Therapeutics Picks Up $30M In Debt Funding

La Jolla-based biopharmaceutical developer Regulus Therapeutics has raised $30M in a growth capital credit facility, from Oxford Finance, the company said this morning. According to Regulus, the proceeds from the loan will go towards working capital needs and advancement of its clinical and pre-clinical development pipeline. Terms of the loan and security agreement were not announced.